Unlocking the potential of engineered immune cell therapy for solid tumors.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39880825.
- Also identified by DOI 10.1038/s41467-025-56527-0 and PMC identifier 11779857.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Adoptive cell therapy has emerged as a promising approach for treating advanced solid malignancies. Genetic engineering techniques represent an exciting area of research for the development of cellular products with enhanced cytotoxicity, phenotype, and metabolism.